Naratriptan Sandoz

Naratriptan, the active ingredient in Naratriptan Sandoz, is a triptan presented as a tablet for cutaneous use. It is used for the acute treatment of migraine attacks in adults. GNH USA supplies Naratriptan Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naratriptan belongs to the triptan class and is used to treat migraine attacks.

- Migraine: provides acute relief of headache pain, nausea and photophobia associated with migraine episodes. - Migraine with aura: reduces the severity and duration of aura‑related symptoms. - Episodic migraine: helps abort individual migraine episodes when taken at onset.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient feeling of light‑headedness. - Fatigue: unusual tiredness after dosing. - Dry mouth: reduced salivation. - Tingling sensation: paresthesia in extremities. - Flushing: warm sensation on the face or neck.

Serious or Rare Side Effects: - Chest discomfort: possible cardiac ischemia. - Severe hypertension: sudden rise in blood pressure. - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Myocardial infarction: rare heart attack. - Stroke: rare cerebrovascular event.

Before using Naratriptan, consider the following precautions: - Cardiovascular assessment: evaluate for history of coronary artery disease or uncontrolled hypertension. - Contraindications: avoid in patients with known hypersensitivity to triptans. - Drug interactions: review concurrent serotonergic medications to reduce risk of serotonin syndrome. - Hepatic/renal function: adjust use in patients with significant liver or kidney impairment. - Pregnancy and lactation: safety not established; discuss risks with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Naratriptan may interact with several drug classes.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension and serotonin syndrome. - Other triptans or ergot derivatives: additive vasoconstrictive effects. - SSRIs, SNRIs, or other serotonergic agents: increased chance of serotonin syndrome. - Certain antihypertensives (e.g., ergotamine): may cause excessive vasoconstriction. - CYP1A2 inhibitors (e.g., fluvoxamine): may raise naratriptan plasma levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance cardiovascular effects. - Oral contraceptives: monitor for increased migraine frequency. - Antidepressants (non‑serotonergic): assess for additive side effects. - Antihistamines: may increase drowsiness. - Alcohol: can exacerbate dizziness and fatigue.